DF-1001
Dragonfly
['dragon', '$ibb', '$xbi']
dragonfly therapeutics to present promising phase 1 results of df-1001 monotherapy dose escalation at asco 2023 annual meeting. more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt